Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog
Tóm tắt
Platelet activation and aggregation in the coronary circulation may be important in the pathogenesis of myocardial ischemia. Molsidomine (M), isosorbide dinitrate (ISDN) and nitroglycerin (NTG) have been found to inhibit platelet aggregationin vitro. In the present study, the activity of these compounds was investigated in a model of coronary artery thrombosisin vivo. Dogs were ancsthetized, thoracotomized, and their heart was exposed. An electrode was inserted into the left circumflex coronary artery and set to rest on the intima. Electrical stimulation (9 V, 150 μA) lasted for 6 h. Compounds (each in 2 dose levels) were given as an i.v. infusion starting 30 min after the beginning of the stimulation and lasting for the duration of the experiment. All control (saline-treated) animals underwent thrombotic occlusion of the coronary artery as assessed by flow measurement. On the other hand, 2/8 dogs treated with the lower M dose and 4/8 dogs treated with the higher M dose did not have a coronary occlusion. Neither ISDN nor NTG, at both doses, prevented the coronary occlusion. In control animals thrombus wet weight was 74.43±11.25 mg. M reduced the thrombus weight in a doserelated manner, while ISDN (marginally) and NTG (significantly at the higher dose) increased this parameter. Following the coronary thrombosis, all control animals developed myocardial infarcts as assessed by the tetrazolium technique. Similarly all animals treated with ISDN and with NTG (at both doses) showed infarcts. However, 3/8 M-dogs did not have a myocardial infarction in the lower as well as in the higher dose groups. The hemodynamic changes induced by the 3 compounds were similar in magnitude. Thus M but not ISDN or NTG showed in thisin-vivo study antithrombotic and consequently antiischemic activity.
Tài liệu tham khảo
Darius H, Ahland B, Rücker W, Klaus W, Peskar BA, Schrör K (1984) Effects of molsidomine and its metabolite SIN 1 on coronary vessel tone, platelets aggregation, and eicosanoid formation in vitro inhibition of 12-HPETE biosynthesis. J. Cardiovasc Pharmacol 6:115–121
De Caterina R, Giannessi D, Crea F, Chierchia S, Bernini W, Gazzetti P, L'Abbate A (1983) Antiplatelet effects of isosorbide dinitrate in man. Z Kardiol 72; Suppl 3:46–51
De Wood M, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897–902
Ellis EF, Oelz O, Roberts II LJ, Payne NA, Sweetman BJ, Nies AS, Oates JA (1976) Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science 193:1135–1137
Fiedler VB (1982) Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs. Can J Physiol Pharmacol 60:1104–1111
Fiedler VB (1983) The effect of nafazatrom (=BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia. Basic Res Cardiol 78:266–280
Folts JD, Gallagher K, Rowe GG (1982) Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelets aggregation? Circulation 65:248–255
Freeman GH, Halton JH (1951) Note on an exact treatment of contingency, goodness of fit, and other problems of significance. Biometrika 38:141–149
Haft JI (1979) Role of blood platelets in coronary artery disease. Am J Cardiol 43:1197–1206
Hirsch PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304:685–691
Hochberg Y (1974) Some generalizations of the T-method in simultaneous inference. J Multivar Anal 4:224–234
Hook BG, Romson JL, Jolly SR, Bailie MB, Lucchesi BR (1983) Effect of zompirac experimental coronary artery thrombosis and ischemic myocardial injury in the conscious dog. J Cardiovasc Pharmacol 5:302–308
Just M, Schraven E, Martorana PA (1983) Effect of thromboxane synthetase inhibition on coronary artery thrombosis in the dog. Naunyn-Schmiedeberg's Arch Pharmacol 322:R 44 (Abs)
Klein HH, Pushmann S, Schaper J, Schaper W (1981) The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch (Pathol Anat) 393:287–297
Kumpuris AG, Luchi RJ, Waddell CC, Miller RR (1980) Production of circulating platelet aggregates by exercise in coronary patients. Circulation 61:62–65
Levy RI, Wiener L, Walinsky P, Lefer AM, Silver MJ, Smith JB (1980) Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation 61:1165–1171
Martorana PA, Göbel H, Kettenbach B, Nitz R-E (1982) Comparison of various methods for assessing infarct-size in the dog. Basic Res Cardiol 77:301–308
Martorana PA, Göbel H, Kettenbach B, Nitz R-E (1982) Effect of molsidomine on infarct size following coronary artery occlusion in the dog. In: Caldarera CM, Harris P (eds) Advances in studies on heart metabolism. CLUEB, Bologna, p 293–298
Martorana PA, Schraven E, Just M, Nitz R-E (1984) The effect of some antianginal drugs in two models (venous and arterial) of thrombosis. Platelets prostaglandins and cardiovascular system. Florence, Febr 8–11 (abstr)
Nienaber Ch, Gottwik M, Winkler B, Schaper W (1983) The relationship between the perfusion deficit, infarct size and time after experimental coronary artery occlusion. Basic Res Cardiol 78:210–226
Nishikawa M, Kanamori M, Hidaka H (1982) Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites. J Pharmacol Exp Ther 220:183–190
Romson JL, Bush LR, Haack DW, Lucchesi BR (1980) The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog. J Pharmacol Exp Ther 215:271–278
Romson JL, Haack DW, Lucchesi BR (1980) Electrical induction of coronary artery thrombosis in the ambulatory canine: a model forin vivo evaluation of antithrombotic agents. Thromb Res 17:841–853
Romson JL, Haack DW, Abrams GD, Lucchesi BR (1981) Prevention of occlusive coronary artery thrombosis by crostacyclin infusion in the dog. Circulation 64:906–914
Sachs L (1969) Statistische Auswertungsmethoden. Springer-Verlag, Berlin Heidelberg New York
Schafer AI, Handin RI (1979) The role of platelets in thrombotic vascular disease. Progr Cardiovasc Dis 22:31–52
Schafer AI, Alexander RW, Handin RI (1980) Inhibition of platelet function by organic vasodilator. Blood 55:649–654
Schaper W, Frenzel H, Hort H (1979) Experimental coronary artery occlusion. I. Measurement of infarct size. Basic Res Cardiol 74:46–53
Scholtholt J, Fiedler VB, Keil M (1978) Die Wirkung von Molsidomin und Nitroglycerin auf die regionale Durchblutung des normalen und akut-ischämischen Myokards. Arzneim-Forsch/Drug Research 28:1619–1624
Schraven E, Martorana PA, Nitz R-E (1983) Effect of molsidomine and nitroglycerin on the increase of coronary venous thromboxane induced by coronary artery thrombosis and myocardial ischemia in the dog. Naunyn-Schmiedeberg's Arch Pharmacol 324, R40 (Abstr)
Shea MJ, Bush LR, Romson JL, Driscoll EM, Lucchesi BR (1982) The effect of diltiazem on coronary artery thrombosis in the conscious canine. Europ J Pharmacol 77:67–70
Sidak Z (1967) Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 62:626–633
Wu KK, Hoak JC (1974) A method for the quantitative detection of platelet aggregates in patients with arterial insuffiency. Lancet 2:924–926